Dechra to Open Aseptic Manufacturing Facility in East Windsor, New Jersey

Dechra, a global leader in veterinary specialty care, announced plans to invest in a manufacturing facility in East Windsor, New Jersey, creating more than 100 new full-time jobs in the region over the next decade.

Small molecule and biologics aseptic manufacturing

Located in New Jersey’s life science, pharmaceutical and high-tech corridor, the facility will support small molecule and biologics aseptic manufacturing. Completed in 2019, the building was designed for aseptic manufacturing. Dechra is completing readiness activities and facility upgrades and expects the site to be fully operational in 2028. The investment is part of the company’s long-term strategy to strengthen U.S.-based manufacturing and supply chain resilience.

Ian MacKellar, chief operating officer of Dechra said:

“Our manufacturing and supply chain capabilities must evolve alongside the business to sustain momentum on our growth journey. The East Windsor facility represents a strategic investment in the capacity, technologies and capabilities required to do just that.”

Dechra CEO Jesper Nordengaard said:

“This site is a long-term investment in our global network and reflects our commitment to not only the future growth of Dechra, but to the local economy in a community close-by our new global headquarters in Boston.”